<DOC>
	<DOCNO>NCT00805480</DOCNO>
	<brief_summary>Loading dose , four arm , double-blind , parallel group , placebo-controlled study compare single multiple dos AIN457 placebo patient diagnosis moderate severe chronic plaque psoriasis .</brief_summary>
	<brief_title>Multiple-loading Dose Regimen Study Patients With Chronic Plaque-type Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Diagnosis plaque psoriasis least 6 month prior screen . The patient must meet following criterion : 1 . Coverage body surface area ( BSA ) 10 % plaque 2 . A score 3 IGA scale 3 . A PASI score least 12 baseline Have form psoriasis require `` plaque psoriasis '' Women childbearing potential Recent use investigational drug treatment biological therapy ( washout period require ) Previous treatment investigational drug Subjects active history clinically significant cardiac , kidney liver abnormality ; Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Plaque</keyword>
	<keyword>psoriasis</keyword>
	<keyword>inflammatory skin disease</keyword>
	<keyword>skin condition , thicken</keyword>
	<keyword>flake</keyword>
	<keyword>scaly patch</keyword>
	<keyword>skin disease</keyword>
</DOC>